Regulations.gov document
Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the…
Other · FDA-2014-D-0329 · posted Nov 24, 2014
Key facts
| Document ID | FDA-2014-D-0329-0005 |
|---|---|
| Title | Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act; Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2014-D-0329 |
| Posted | Nov 24, 2014 |
| Comment period opens | Nov 24, 2014 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: